Table 2.
Possible clinical predictors of muscular gene expression.
| Variable | Variable type (levels or range) | Pillai’s trace | Num Df | Den Df | p |
|---|---|---|---|---|---|
| Group | Factor (Control, ERPR, HER2, TN, and TP) | 0.51 | 12 | 111 | 0.04* |
| Serum albumin | Numeric | 0.20 | 3 | 29 | 0.08** |
| N staging | Factor (N0, N1, N1a, N2, N3) | 0.52 | 12 | 84 | 0.15 |
| # of Chemotherapy Txs | Numeric (0-2) | 0.10 | 3 | 38 | 0.25 |
| # of Radiation Txs | Numeric (0-1) | 0.10 | 3 | 38 | 0.26 |
| T Staging | Factor (T1, T1a, T2, T2A, T3, T4) | 0.51 | 15 | 81 | 0.37 |
| # of Hormonal Txs | Numeric (0-1) | 0.07 | 3 | 38 | 0.43 |
| LBM % | Numeric | 0.12 | 3 | 19 | 0.45 |
| BMI | Numeric | 0.05 | 3 | 38 | 0.56 |
| Ave. daily BMI change | Numeric | 0.03 | 3 | 37 | 0.78 |
| M staging | Factor (M0, MX) | 0.01 | 3 | 29 | 0.95 |
Num numerator, Den denominator, Df degrees of freedom, LBM % lean body mass as a percentage of total body mass, Ave average, T tumor, N lymph node, M metastatic, Txs courses of treatments.
*p < 0.05.
**p < 0.10.